# Cost Tracking Visualization Design

## Overview
This document describes the visualization components for cost tracking and workload analysis in the VEGF simulation.

## 1. Cost Configuration Panel (Sidebar)

### Layout
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸ’° Cost Parameters              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Drug Costs                      â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ Eylea 2mg (Â£)               â”‚ â”‚
â”‚ â”‚ [===|=======] 800           â”‚ â”‚
â”‚ â”‚  400        1200            â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                 â”‚
â”‚ Visit Cost Model                â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
â”‚ â”‚ â–¼ NHS Standard 2025         â”‚ â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
â”‚                                 â”‚
â”‚ [?] Component Costs             â”‚
â”‚ â€¢ Injection: Â£150               â”‚
â”‚ â€¢ OCT Scan: Â£75                 â”‚
â”‚ â€¢ Clinical Review: Â£120         â”‚
â”‚ â€¢ VA Test: Â£25                  â”‚
â”‚                                 â”‚
â”‚ â˜ Include virtual clinics       â”‚
â”‚ â˜ Apply biosimilar pricing      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Features
- Slider for drug cost adjustment
- Dropdown for cost model selection
- Expandable section showing component costs
- Checkboxes for cost scenarios

## 2. Main Dashboard Layout

### Tab Structure
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Simulation  â”‚ Analysis     â”‚ ðŸ’° Economics    â”‚ Patient Explorer â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## 3. Economics Tab Components

### 3.1 Summary Metrics (Top Row)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Total Cost      â”‚ Active Patients â”‚ Cost/Patient    â”‚ Cost/Vision Yr  â”‚
â”‚ Â£2.4M          â”‚ 245/300        â”‚ Â£8,750         â”‚ Â£15,200        â”‚
â”‚ â–² 5.2%         â”‚ 81.7%          â”‚ â–¼ 3.1%         â”‚ â–¼ 8.5%         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 3.2 Workload Timeline (Main Chart)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Clinical Workload Over Time                                      â”‚
â”‚                                                                  â”‚
â”‚ 250 â”¤                                    â•±â•²                      â”‚
â”‚     â”‚                                   â•±  â•²                     â”‚
â”‚ 200 â”¤                     â•±â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•¯    â•²                   â”‚
â”‚     â”‚                    â•±                    â•²___               â”‚
â”‚ 150 â”¤        â•±â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â•¯ [Injections]         â•²â”€â”€â”€â”€â”€â”€         â”‚
â”‚     â”‚       â•±                                            â•²       â”‚
â”‚ 100 â”¤ â”€â”€â”€â”€â”€â•¯  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â•²     â”‚
â”‚     â”‚         â”‚  Decision-maker visits                  â”‚ â•²    â”‚
â”‚  50 â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ â”‚
â”‚     â”‚                                                          â”‚
â”‚   0 â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚     0    6    12    18    24    30    36    42    48    54    60â”‚
â”‚                         Months from Start                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 3.3 Cost Breakdown (Left Column)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Cost by Component          â”‚  â”‚ Cost by Year               â”‚
â”‚                            â”‚  â”‚                            â”‚
â”‚       Drug                 â”‚  â”‚ Year 1: Â£450K (38%)       â”‚
â”‚       65%  â•±â”€â”€â”€â”€â”€â•²         â”‚  â”‚ Year 2: Â£280K (23%)       â”‚
â”‚          â•±         â•²       â”‚  â”‚ Year 3: Â£210K (18%)       â”‚
â”‚        â•±             â•²     â”‚  â”‚ Year 4: Â£155K (13%)       â”‚
â”‚      â”‚   Procedures   â”‚    â”‚  â”‚ Year 5: Â£105K (9%)        â”‚
â”‚      â”‚      20%       â”‚    â”‚  â”‚                            â”‚
â”‚       â•²             â•±      â”‚  â”‚ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Y1    â”‚
â”‚ OCT 8% â•²â”€â”€â”€â”€â”€â”€â”€â”€â”€â•± Other  â”‚  â”‚ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Y2           â”‚
â”‚         Review 7%          â”‚  â”‚ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Y3              â”‚
â”‚                            â”‚  â”‚ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Y4                 â”‚
â”‚ Total: Â£1,200,000         â”‚  â”‚ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ Y5                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 3.4 Protocol Comparison (Right Column)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ T&E vs T&T Comparison                                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                        T&E          T&T         Difference   â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚
â”‚ Total Cost:         Â£1.2M        Â£1.4M         -Â£200K (-14%) â”‚
â”‚ Drug Cost:          Â£780K        Â£910K         -Â£130K (-14%) â”‚
â”‚ Visit Cost:         Â£420K        Â£490K         -Â£70K (-14%)  â”‚
â”‚                                                              â”‚
â”‚ Injections:         1,050        1,225         -175 (-14%)   â”‚
â”‚ Decision Visits:    1,050          350         +700 (+200%)  â”‚
â”‚                                                              â”‚
â”‚ Cost/Patient:       Â£8,750       Â£10,200       -Â£1,450       â”‚
â”‚ Cost/Vision Year:   Â£15,200      Â£14,800       +Â£400         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 3.5 Resource Utilization Heatmap
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Monthly Resource Utilization                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚        Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec      â”‚
â”‚ 2025   â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆâ–ˆ â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ       â”‚
â”‚ 2026   â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆâ–ˆ  â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ        â”‚
â”‚ 2027   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ        â”‚
â”‚ 2028   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–ˆ   â–‘   â–‘        â”‚
â”‚ 2029   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘   â–‘        â”‚
â”‚                                                              â”‚
â”‚ â–ˆâ–ˆâ–ˆ >200 visits  â–ˆâ–ˆ 100-200  â–ˆ 50-100  â–‘ <50 visits        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## 4. Interactive Features

### 4.1 Hover Information
- **Workload Timeline**: Show exact counts on hover
- **Cost Breakdown**: Display amounts and percentages
- **Comparison Table**: Highlight differences

### 4.2 Filtering Options
```
Time Period: [All Time â–¼] [Custom Range]
Patient Group: [All Patients â–¼] [Active Only] [Discontinued]
Protocol: [Both â–¼] [T&E Only] [T&T Only]
```

### 4.3 Export Options
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸ“Š Export Options                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ [Download Cost Report (PDF)]        â”‚
â”‚ [Export Data (CSV)]                 â”‚
â”‚ [Save Charts (PNG)]                 â”‚
â”‚ [Generate NICE Format]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## 5. Detailed Views

### 5.1 Patient-Level Cost View
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Patient Cost Distribution                                    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  40 â”¤                    â•±â•²                                   â”‚
â”‚     â”‚                   â•±  â•²                                  â”‚
â”‚  30 â”¤                  â•±    â•²                                 â”‚
â”‚     â”‚                 â•±      â•²                                â”‚
â”‚  20 â”¤                â•±        â•²                               â”‚
â”‚     â”‚               â•±          â•²                              â”‚
â”‚  10 â”¤          ____â•±            â•²____                         â”‚
â”‚     â”‚     ____â•±                      â•²____                    â”‚
â”‚   0 â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚     Â£0    Â£5K   Â£10K  Â£15K  Â£20K  Â£25K  Â£30K  Â£35K  Â£40K   â”‚
â”‚                      Cost per Patient                        â”‚
â”‚                                                              â”‚
â”‚ Mean: Â£12,450  |  Median: Â£11,200  |  SD: Â£5,670           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### 5.2 Time-to-Event Cost Analysis
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Cumulative Cost by Patient Outcome                          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Â£25K â”¤                                    _____ Discontinued â”‚
â”‚      â”‚                               ____â•±                    â”‚
â”‚ Â£20K â”¤                          ____â•±   _____ Still Active   â”‚
â”‚      â”‚                     ____â•±  ____â•±                      â”‚
â”‚ Â£15K â”¤                ____â•±  ____â•±                           â”‚
â”‚      â”‚           ____â•±  ____â•±                                â”‚
â”‚ Â£10K â”¤      ____â•±  ____â•± _____ Vision Maintained            â”‚
â”‚      â”‚ ____â•±  ____â•± ____â•±                                    â”‚
â”‚  Â£5K â”¤â•±  ____â•± ____â•±                                         â”‚
â”‚      â”‚__â•± ____â•±                                              â”‚
â”‚   Â£0 â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”‚      0    12    24    36    48    60    72    84    96      â”‚
â”‚                    Months in Treatment                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## 6. Mobile/Responsive Design

### Tablet View (768px)
- Stack cost breakdown and comparison vertically
- Maintain workload timeline full width
- Collapse detailed metrics into expandable cards

### Mobile View (480px)
- Single column layout
- Swipeable metric cards
- Simplified charts with essential data only
- Bottom navigation for tab switching

## 7. Color Scheme

### Primary Colors
- **Injections**: `#1f77b4` (Blue)
- **Decision Visits**: `#ff7f0e` (Orange)
- **Drug Costs**: `#2ca02c` (Green)
- **Procedure Costs**: `#d62728` (Red)
- **Other Costs**: `#9467bd` (Purple)

### Status Colors
- **Success/Savings**: `#28a745` (Green)
- **Warning/Increase**: `#ffc107` (Amber)
- **Alert/High Cost**: `#dc3545` (Red)
- **Neutral**: `#6c757d` (Gray)

## 8. Accessibility

### Features
- High contrast mode toggle
- Colorblind-friendly palette option
- Screen reader descriptions for all charts
- Keyboard navigation support
- Data tables as alternative to visualizations

### ARIA Labels
```html
<div role="img" aria-label="Workload timeline showing 150 injections 
     and 50 decision visits in January 2025">
  <!-- Chart content -->
</div>
```

## 9. Performance Considerations

### Data Aggregation
- Pre-calculate monthly summaries
- Cache cost calculations
- Lazy load detailed patient data
- Progressive chart rendering

### Update Strategy
- Real-time updates during simulation
- Batch updates every 100ms
- Debounce slider inputs
- Virtualize large data tables